Monday, 25 July 2011

Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio

Raptor holds exclusive, worldwide licenses to these patent applications, which are owned by the Regents of the University of California, and are based on work performed at the University of California, San Diego ("UCSD"). Both patent applications are expected to issue before the end of 2011. "In ...

Related News:-

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
Related Posts Plugin for WordPress, Blogger...